Disposable EEG Electrode Market Size, Share, and COVID-19 Impact Analysis By Product (Cup, Patch, Needle, and Others), By Application (Diagnostics and Therapeutics), By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2024-2032

The disposable electroencephalograph (EEG) electrode measures brain activities through electrical activation. The electrodes are attached on the scalp, and the electrical activity of brain cells is recorded. These electrodes are used in the diagnosis of various neurological disorders. Apart from their basic applications, these disposable EEG electrodes have significant benefits over reusable EEG electrodes. The reusable EEG electrodes pose a certain risk of infection because of cross-contamination, which can be eliminated using disposable EEG electrodes.

The rise in the prevalence of neurological disorders such as epilepsy, Parkinson's disease, etc., is expected to fuel the demand for these EEG electrodes. For instance, according to the statistics published by World Health Organization (WHO) in 2022, around 50 million people worldwide are affected by epilepsy. Similarly, four out and 10 per 1000 people have active epilepsy. Furthermore rising geriatric population also contributes to market growth. Also, increasing research and development activities to introduce advanced disposable EEG electrodes are expected to generate excellent opportunities for the market.

However, the rising use of alternatives such as reusable EEG electrodes and lack of awareness regarding hospital-acquired infections, especially in emerging nations, may restrain the market growth.

Impact of COVID-19 on the Disposable EEG Electrode Market

The outbreak of the COVID-19 pandemic impacted the global market negatively. The pandemic halted elective and non-emergent tests and procedures due to factors such as the lockdown and the risk of infection among patients. For instance, according to an article published by the National Institutes of Health (NIH) in 2021, the COVID-19 pandemic had affected the clinical practice and research activities of electroencephalography (EEG) in various countries. The survey reports that out of 15 clinical centers, 11 had a complete stoppage of all EEG activities. Also, in 25 research settings, there was a complete stoppage of activities.

Similarly, the COVID-19 pandemic represented an unpredictable situation for disposable EEG electrode manufacturers due to the disruptions in the supply chain during the period. Some of the prominent market players witnessed a decline in annual revenue. For instance, major players, such as CONMED Corporation, have witnessed a drop of 0.8% in 2020 compared to 2019. Also, the company witnessed a recovery in the year 2021.

The market recovered to its pre-pandemic growth level in terms of patient visits as well as company sales in 2021. The market is anticipated to grow at a pre-pandemic growth rate during the forecast period 2023-2030.

Key Insights

• Prevalence of Key Neurological Diseases, By Key Countries, 2022.


• Key Industry Developments (Mergers, Partnerships, and Acquisitions).


• New Product Launches, By Key Players.


• Technological Advancements in EEG Electrodes.


• Impact of COVID-19 on the Global Disposable EEG Electrode Market.

Analysis by Product:

Based on the product, the global disposable EEG electrode market is segmented into the cup, patch, needle, and others. The cup electrode is expected to hold the lion’s share in the global market. The cup EEG electrode has optimized signal quality due to larger electrode surface and allows easy placement on the scalp of the patient. These clinical benefits, and rising initiatives by key market players to launch new products in this segment propels segmental growth. According to an article published by Neurology Insights in 2020, a study reported that 25.0% of reusable EEG cup electrodes caused infection among neurological disorder patients. In that case, the disposable EEG electrodes may help to manage cross-contamination issues. Such factors fuel the market growth.

Analysis by Application:

Based on the application, the market is segmented into diagnostics and therapeutics. The diagnostics segment is expected to account for a significant share due to its extensive use in the detection of neurological disorders. These electrodes are also considered cost-effective as compared to other complex reusable EEG electrodes. Such factors boost strong product adoption in the market. According to an article published by NIH in 2019, a base-case analysis reported that disposable EEG electrodes are cost-effective compared with reusable EEG electrodes. Also, it reduces sepsis cases that are caused by the usage of EEG electrodes in various diagnostic procedures. The therapeutics segment held a lower percentage in the market. Similarly, increasing the use of specific neurological therapies is projected to augment the therapeutics segment.

Analysis by End User:

Based on the end user, the market is segmented into hospitals & clinics, diagnostic centers, and others. The hospitals & clinics segment is expected to account significant share due to the efficient detection of neurological disorders in hospitals as they are primary healthcare centers. Also, growing research initiatives to develop advanced products augment segmental growth. According to an article published by Multidisciplinary Digital Publishing Institute (MDPI) in 2022, a study was funded by European Union to develop a disposable EEG cap for the neonatal intensive care units (NICU). Such rising developments boost the segmental growth in the market.

Regional Analysis:

Among regions, North America accounted for a significant global market share. The dominant share is attributed to robust initiatives by key players to introduce new products and expand their distribution network to make the product readily available in the market. Also, strong product adoption and the increasing prevalence of brain disorders propel regional growth. According to statistics of Cnacer.Net (2022), approximately 25,050 adults will be diagnosed with primary cancerous brain and spinal cord tumors in the U.S. Such scenario fuels the regional growth in the global market.

Key Players Covered

The report will include the profiles of key players such as Brain Scientific, Inc., Ambu A/S, CONMED Corporation, Natus Medical Incorporated, Koninklijke Philips N.V., GE HealthCare, SPES MEDICA SRL, TECHNOMED, and others.

Segmentation

Key Industry Developments

• April 2020: Brain Scientific, Inc. launched an online store to sell sanitized EEG products such as FDA-cleared NeuroCap and NeuroEEG.


• April 2020: Nihon Kohden Corporation announced the launch of the Premium Disposable Gold Cup EEG Electrode.


• January 2020: Dymedix Diagnostics received Section 510 (k) premarket notification of clearance for Disposable Gold Cup EEG Electrodes from the U.S. FDA.